BridgeMD
New treatment option for Surgeries Undergoing General Anesthesia
Official title Impact of Intraoperative Oxygenation Practices on Patient Outcomes
ClinicalTrials.gov ID: NCT07224243
What this study is testing
- What it's testing
- This multicenter, cluster-randomized, cluster-crossover clinical trial evaluates the impact of three intraoperative FiO2 (Fraction of Inspired Oxygen) oxygenation strategies-lower (FiO₂ 0.21-0.40), intermediate (FiO₂ 0.40-0.80), and higher (FiO₂ 0.80-1.00)-on postoperative organ injury and mortality in adult surgical patients. The trial aims to determine the optimal oxygenation strategy to improve perioperative outcomes.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Patient located in a participating operating room
- Planned surgery includes tracheal intubation
You likely can't join if
- Patient is known to be less than 18 years old
- Patient is known to be pregnant
- Patient is known to be a prisoner.
- Patient is American Society of Anesthesiologists (ASA) classification-6 (i.e., organ donor)
- Patient's planned surgical case includes open heart surgery, defined as surgery on the heart or ascending aorta requiring sternotomy or thoracotomy.
- Patient's planned procedure requires prolonged apnea, bronchoscopy, airway surgery, or one-lung ventilation.
See the full eligibility criteria
- Patient located in a participating operating room
- Planned surgery includes tracheal intubation
- Patient is known to be less than 18 years old
- Patient is known to be pregnant
- Patient is known to be a prisoner.
- Patient is American Society of Anesthesiologists (ASA) classification-6 (i.e., organ donor)
- Patient's planned surgical case includes open heart surgery, defined as surgery on the heart or ascending aorta requiring sternotomy or thoracotomy.
- Patient's planned procedure requires prolonged apnea, bronchoscopy, airway surgery, or one-lung ventilation.
- Patient's planned surgical case includes use of extracorporeal membrane oxygenation (ECMO).
- Patient is known to have a history of bleomycin treatment.
- Patient was enrolled in the trial in the prior 30 days.
The study team makes the final eligibility decision.
Where it's taking place
- Ann Arbor, Michigan, United States
- Omaha, Nebraska, United States
- Nashville, Tennessee, United States
- Salt Lake City, Utah, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ann Arbor, Michigan, United States; Omaha, Nebraska, United States; Nashville, Tennessee, United States; Salt Lake City, Utah, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.